← Plastic & Cosmetic Surgery Anesthesia
PONV and the Aesthetic Patient Experience: Why Emergence Quality Drives Your Reviews
Your surgical result will be judged in six months. Your anesthesia will be judged in the recovery room, and again at 9 p.m. that night when the patient is texting her friend about how the day went. In a specialty where patients pay out of pocket, choose you from a photo gallery, and generate most of your new volume through referral and review, the emergence experience is not a clinical footnote. It is part of the product.
The uncomfortable fact is that the aesthetic patient population is close to the worst-case profile for postoperative nausea and vomiting. Not by coincidence — by definition.
Your Average Patient Scores a 4 out of 4
The Apfel simplified risk score predicts PONV from four factors: female sex, non-smoking status, a history of PONV or motion sickness, and the use of postoperative opioids. The validated 24-hour PONV risk runs approximately 10% with zero risk factors, 21% with one, 39% with two, 61% with three, and 79% with all four.1
Now describe a typical cosmetic surgery patient: female, health-conscious and therefore a non-smoker, and going home on opioids after an abdominoplasty or augmentation. That is three factors before you ask a single question. Add a history of motion sickness — common, and rarely volunteered unless asked — and she is in the 79% band. She is not an unusual case. She is your Tuesday.
Layer on the procedure-specific aggravators that define aesthetic surgery and the risk climbs further: long operative times in combination cases, abdominal wall plication, head-and-neck positioning in facial work, and the volatile anesthetic technique still used as a default in many office ORs.
What PONV Actually Costs an Aesthetic Practice
In a hospital, PONV is a quality metric. In a cash-pay office OR, it is a direct financial event with four distinct costs:
- PACU time you are paying for. A vomiting patient does not meet discharge criteria. Recovery nurses, the anesthesia provider, and the facility stay committed to a case that should have been closed out — and in a single-recovery-bay office, that patient is blocking the next one.
- Unplanned transfers and after-hours calls. Intractable nausea is one of the more common reasons an outpatient cosmetic case becomes an unplanned admission or an emergency-department return. Both are reportable events under most accreditation frameworks — the quality data your surveyor reviews, as covered in Office-Based Surgery Accreditation.
- Surgical risk, not just discomfort. Retching after abdominoplasty stresses a fresh plication and abdominal closure. After a facelift or rhinoplasty, the venous pressure spike from vomiting is a hematoma risk. PONV in aesthetic surgery is not merely unpleasant — it can threaten the result the patient paid for.
- The review. This is the one most practices under-price. A patient who is thrilled with her result but describes “I was throwing up for six hours” in a four-star review has just changed the conversion rate of every prospect who reads it. Patients have long been shown to place real monetary value on avoiding PONV — they will pay out of pocket for prophylaxis when offered the choice. Your prospective patients are making the same calculation while reading your reviews.
This Is a Solved Problem — When Someone Owns It
The Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting establish the operating principle plainly: prophylaxis should be multimodal and scaled to risk, with multiple agents from different classes for high-risk patients rather than a single rescue drug given after the patient is already sick.2 For a patient population that sits at three or four Apfel factors as a baseline, “we’ll give her Zofran if she needs it” is not a plan. It is the absence of one.
The levers that matter in aesthetic surgery:
- TIVA instead of volatile agents. A propofol-based total intravenous technique meaningfully reduces PONV relative to inhalational anesthesia, and it produces the clear-headed emergence aesthetic patients describe favorably. In a population this high-risk, technique selection is the single highest-yield decision.
- Combination prophylaxis given on schedule. Agents from different mechanistic classes — a 5-HT3 antagonist, dexamethasone, and a scopolamine patch or NK-1 antagonist as risk dictates — dosed at the right point in the case rather than at the end.
- Opioid-sparing multimodal analgesia. Every opioid milligram you remove takes an Apfel factor with it. Regional and field blocks — TAP blocks for abdominoplasty, pectoral blocks for breast work — plus scheduled acetaminophen and NSAIDs where the surgeon permits, plus long-acting local infiltration, reduce both nausea and the opioid script the patient goes home with.
- Euvolemia and normothermia. Adequate fluid management and active warming through a long case both contribute to a smoother recovery, and matter more the longer the case runs.
- A rescue plan using a different class than the prophylaxis. Repeating the drug that already failed is the most common rescue error.
Emergence Quality Is a Brand Asset
There is a version of the recovery-room experience that patients describe as “I woke up and I felt fine, I couldn’t believe it was over.” That version is not luck. It is a deliberately constructed anesthetic: risk scored in advance, technique chosen for this population rather than by habit, prophylaxis layered before the stimulus arrives, opioids minimized by design, and a provider who has done enough aesthetic cases to know that the last twenty minutes of the anesthetic determine what the patient remembers about the whole day.
Practices that market on patient experience should be asking their anesthesia provider what their actual PONV rate is. If no one is measuring it, that is the answer.
How Illume Approaches It
Illume Anesthesia providers work aesthetic cases every week, and PONV-minimizing technique is our default rather than an upgrade. We risk-score every patient before the day of surgery as part of the pre-screening protocol that also catches the medication and comorbidity issues discussed in GLP-1 Medications and Anesthesia Risk. We build TIVA-based, opioid-sparing plans for the long combination days described in Long Combination Cases, and we track outcomes against hospital-level quality metrics rather than asking you to take our word for it.
The goal is straightforward: your patient’s memory of the day should match the result you gave her.
What Is Your Practice’s Actual PONV Rate?
If you don’t know, that is worth 15 minutes. A discovery call is enough to review your current technique and recovery data and show you what a purpose-built aesthetic anesthetic looks like.